Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;22(1):81-89.
doi: 10.1007/s11154-020-09591-4. Epub 2020 Sep 16.

Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome

Affiliations
Review

Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome

Manuel H Aguiar-Oliveira et al. Rev Endocr Metab Disord. 2021 Mar.

Abstract

Since 1994, we have been studying an extended kindred with 105 subjects (over 8 generations) residing in Itabaianinha County, in the Brazilian state of Sergipe, who have severe isolated GH deficiency (IGHD) due to a homozygous inactivating mutation (c.57 + 1G > A) in the GH releasing hormone (GHRH) receptor (GHRHR) gene. Most of these individuals have never received GH replacement therapy. They have low GH, and very low and often undetectable levels of serum IGF-I. Their principal physical findings are proportionate short stature, doll facies, high-pitched-voice, central obesity, wrinkled skin, and youthful hair with delayed pigmentation, and virtual absence of graying. The newborns from this cohort are of normal size, indicating that GH is not needed for intra-uterine growth. However, these IGHD individuals exhibit a myriad of phenotypic changes throughout the body, with a greater number of beneficial than harmful consequences. This GHRH signal disruption syndrome has been a valuable model to study the GH roles in body size and function. This reviews summarized the findings we have reported on this cohort.

Keywords: GH; GHRH; GHRH receptor; IGF-I; IGF-II.

PubMed Disclaimer

References

    1. Livingstone C, Borai A. Insulin-like growth factor-II: its role in metabolic and endocrine disease. Clin Endocrinol. 2014;80:773–81. - DOI
    1. Aguiar-Oliveira MH, Bartke A. Growth hormone deficiency: health and longevity. Endocr Rev. 2019;40:575–601. - PubMed - DOI
    1. Salvatori R, Hayashida CY, Aguiar-Oliveira MH, Phillips JA III, Souza AH, Gondo RG, et al. Familial isolated growth hormone deficiency due to a novel mutation in the growth hormone releasing hormone receptor. J Clin Endocrinol. 1999;84:917–23.
    1. Souza AH, Salvatori R, Martinelli CE Jr, Carvalho WM, Menezes CA, Barretto ES, et al. Growth or somatotrophic hormone: new perspectives in isolated GH deficiency after description of the mutation in the GHRH receptor gene in individuals of Itabaianinha County, Brazil. Arq Bras Endocrinol Metabol. 2004;48:406–13. - PubMed - DOI
    1. Aguiar-Oliveira MH, Souza AHO, Oliveira CRP, Campos VC, Oliveira-Neto LA, Salvatori R. MECHANISMS IN ENDOCRINOLOGY: the multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. Eur J Endocrinol. 2017;177:R85–97. - PubMed - DOI

Substances

LinkOut - more resources